Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases
Damijan Knez, Daniel Diez‐Iriepa, Mourad Chioua, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 2152-2175
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders
Ayodeji O. Egunlusi, Jacques Joubert
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 639-639
Open Access | Times Cited: 18
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116569-116569
Closed Access | Times Cited: 12
A multifunctional natural treasure based on a “one stone, many birds” strategy for designing health-promoting applications: Tordylium apulum
Nilofar Nilofar, Gokhan Zengin, Abdullahi İbrahim Uba, et al.
Food Bioscience (2024) Vol. 62, pp. 105088-105088
Closed Access | Times Cited: 7
Dual-Target Inhibitors Based on Acetylcholinesterase: Novel Agents for Alzheimer's Disease
Xingyi Zhao, Qiaoguan Hu, Xiaoqian Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116810-116810
Closed Access | Times Cited: 6
Design, Synthesis, and Biological Evaluation of Ferulic Acid Template-Based Novel Multifunctional Ligands Targeting NLRP3 Inflammasome for the Management of Alzheimer’s Disease
Gourav Singh, Gauri Shankar, Samir Ranjan Panda, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 7, pp. 1388-1414
Closed Access | Times Cited: 5
32nd Annual GP2A Medicinal Chemistry Conference
Jean‐Jacques Hélesbeux, Florence O. McCarthy, Maria Manuel Silva, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Potential Azo-8-hydroxyquinoline derivatives as multi-target lead candidates for Alzheimer’s disease: An in-depth in silico study of monoamine oxidase and cholinesterase inhibitors
Fatima Zahra Guerguer, Bouchra Rossafi, Oussama Abchır, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317261-e0317261
Open Access
Artificial intelligence-driven development of natural multi-target derivatives with BuChE inhibitory activity for treating Alzheimer's disease
Qiyao Zhang, Yuting Li, Qunhua Jin, et al.
Chinese Chemical Letters (2025), pp. 110964-110964
Closed Access
Antioxidants in Anti-Alzheimer's Disease Drug Discovery
Jianan Guo, Yalan Zhu, Jia Zhi, et al.
Ageing Research Reviews (2025) Vol. 107, pp. 102707-102707
Closed Access
Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer’s disease
Zhipei Sang, Shuheng Huang, Wanying Tan, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Nicotinamide derivatives protect the blood-brain barrier against oxidative stress
Antonio Zandona, Anikó Szecskó, Suzana Žunec, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118018-118018
Closed Access
Exogenous nitric oxide induces production of phenolic compounds, enzyme inhibitory properties and antioxidant capacity through activating the phenylpropanoid pathway in sage (Salvia officinalis) leaves
Hakan Terzi, H T Yalçin, Mustafa Yıldız, et al.
South African Journal of Botany (2025) Vol. 180, pp. 811-819
Closed Access
Chiral carbon dots based on ternary carbon sources: A multifunctional therapeutic agent for Cu2+-induced Alzheimer's disease
Lina Bao, Luo Wan-chun, Qinying Li, et al.
Carbon (2024) Vol. 228, pp. 119333-119333
Closed Access | Times Cited: 3
Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer’s Disease
Gourav Singh, Sunil Kumar, Samir Ranjan Panda, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 15, pp. 2756-2778
Closed Access | Times Cited: 3
Unveiling piperazine-quinoline hybrids as potential multi-target directed anti-Alzheimer’s agents: design, synthesis and biological evaluation
Afzal Nagani, Moksh Shah, Salman Patel, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 2
Therapeutic Effects of a New Bithiophene against Aluminum -Induced Alzheimer’s Disease in a Rat Model: Pathological and Ultrastructural approach
Kholoud AbdEl-Raouf, Monir A. El-Ganzuri, Wael M. El‐Sayed
Tissue and Cell (2024) Vol. 90, pp. 102529-102529
Closed Access | Times Cited: 2
Discovery of New Highly Potent Histamine H3 Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors
R.S. Malek, Kinga Sałat, Perle Totoson, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 18, pp. 3363-3383
Closed Access | Times Cited: 2
Characterization of the chemical profiles and biological activities of Thesium bertramii Azn. Extracts using a combination of in vitro, in silico, and network pharmacology methods
Eulogio J. Llorent‐Martínez, Sakina Yagi, Gokhan Zengin, et al.
Fitoterapia (2024) Vol. 180, pp. 106329-106329
Closed Access | Times Cited: 2
Anti-proliferative activity of nitroquinolone fused acylhydrazones as non-small cell human lung cancer agents
Vandana Nandakumar, Sundarasamy Amsaveni, Kaviyarasu Adhigaman, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 7, pp. 1331-1343
Closed Access | Times Cited: 6
Neuroprotective and antioxidant properties of new quinolylnitrones in in vitro and in vivo cerebral ischemia models
Beatriz Chamorro, Sara Izquierdo-Bermejo, Julia Serrano, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Design, synthesis, and biological evaluation of new bis-benzylisoquinoline-based analogues as potential neuromuscular blocking agents
Lin Fu, Gan Yu, Xiaofeng Liu, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 108, pp. 129793-129793
Closed Access | Times Cited: 1
Cytotoxic, antioxidant, and enzyme inhibitory activities of Centaurea stapfiana extracts and their HPLC-ESI-QTOF-MS profiles: Insights into an unexplored Centaurea species
Gökhan Zengin, Álvaro Fernández‐Ochoa, María de la Luz Cádiz‐Gurrea, et al.
Fitoterapia (2024) Vol. 179, pp. 106207-106207
Closed Access | Times Cited: 1
Synthesis, biological evaluation and molecular docking studies of novel mixed-ligand Schiff base/8-hydroxyquinoline metal complexes
Ayman A. O. Younes
Materials Express (2023) Vol. 13, Iss. 12, pp. 2110-2127
Closed Access | Times Cited: 3
Design, Synthesis, and Biological Evaluation of New Bis-Benzylisoquinoline-Based Analogues as Potential Neuromuscular Blocking Agents
Lin Fu, Gan Yu, Xiaofeng Liu, et al.
(2024)
Closed Access
Page 1 - Next Page

Scroll to top